Australia
# |
Name |
Revenue |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 14.69 B
|
June 30, 2024 | USD 169.95 | -0.56% |
|
Australia |
|
2 |
USD 3.27 M
|
June 30, 2024 | USD 2.04 | -5.56% |
|
Australia |
|
3 |
USD 2.68 M
|
June 30, 2024 | USD 4.80 | 5.03% |
|
Australia |
|
4 |
USD 2.56 M
|
June 30, 2024 | USD 2.09 | 0.97% |
|
Australia |
|
5 |
USD 12.00 K
|
June 30, 2024 | USD 1.67 | 2.45% |
|
Australia |
The Vaccines company in Australia with the highest Revenue is CSL Limited (ASX: CSL.AX) at USD 14.69 B.
The Vaccines company in Australia with the lowest Revenue is Incannex Healthcare Limited (NasdaqGM: IXHL) at USD 12.00 K.
The top 10 Vaccines companies in Australia by Revenue are CSL Limited, Immuron Limited, Alterity Therapeutics Limited, Immutep Limited and Incannex Healthcare Limited.
The bottom 10 Vaccines companies in Australia by Revenue are Incannex Healthcare Limited, Immutep Limited, Alterity Therapeutics Limited, Immuron Limited and CSL Limited.